PBMs for Better or Worse

2021-02-11T16:01:43+00:00

With enrollment in Medicare Part D and specialty drug costs exploding, it’s no surprise that forecasts predict 7 percent annual growth for PBMs over the next several years. Two trends noted in the report were the continued acquisition or startup of PBMs by insurance carriers and the need for employers to better understand their options [...]

PBMs for Better or Worse2021-02-11T16:01:43+00:00

Fighting Specialty Drug Costs

2017-09-25T09:30:17+00:00

To help control rising specialty drug costs, the National Business Group on Health has issued a lengthy report including 5 public policy recommendations they hope will educate the marketplace and encourage effective, strategic partnerships. According to NBGH officials, plan design is the key to managing the use of specialty prescriptions as well as the costs. [...]

Fighting Specialty Drug Costs2017-09-25T09:30:17+00:00
Go to Top